Great news! We warmly congratulate Baihui Pharmaceutical on successfully being recognized as a high-tech enterprise in the first batch of 2021 applications and filings.
Release date:
2021-11-03
2021 On October 14, the Office of the National Leading Group for the Management of High-Tech Enterprise Recognition released the "Notice on Publicizing the List of High-Tech Enterprises Recognized and Filed in the First Batch of 2021 by Guangxi Zhuang Autonomous Region." Baihui Pharmaceutical successfully passed the public announcement process as a "High-Tech Enterprise," marking the company's second recognition as a national-level high-tech enterprise—following its previous certifications in 2014 and 2018.
High-tech enterprises generally refer to companies that continuously engage in research and development as well as the commercialization of technological achievements—activities aligned with the "National Key Areas of High Technology Supported by the State." These enterprises develop core, independent intellectual property rights that form the foundation for their business operations. As knowledge- and technology-intensive economic entities, high-tech enterprises represent an indispensable badge of honor for science and technology firms that rely on innovation to thrive.
Baihui Pharmaceutical will continue to uphold the philosophy of "pioneering and innovation," further enhancing its scientific research capabilities, cultivating a robust team of research professionals, and strengthening the company's core competitiveness. We remain committed to the strategy of driving national development through technological innovation and talent cultivation, contributing to the long-term, sustainable growth of China's pharmaceutical industry. Above all, we will steadfastly fulfill our mission of providing high-quality medicines that truly benefit the people!